Caveolae, Lipid Rafts, and Vascular Disease
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 15 (3), 92-96
- https://doi.org/10.1016/j.tcm.2005.04.001
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Expression of Caveolin-1 Enhances Cholesterol Efflux in Hepatic CellsJournal of Biological Chemistry, 2004
- Genetic Ablation of Caveolin-1 Confers Protection Against AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Disruption of the Caveolin-1 Gene Impairs Renal Calcium Reabsorption and Leads to Hypercalciuria and UrolithiasisThe American Journal of Pathology, 2003
- A Role for Lipid Shells in Targeting Proteins to Caveolae, Rafts, and Other Lipid DomainsScience, 2002
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Caveolin-3 Null Mice Show a Loss of Caveolae, Changes in the Microdomain Distribution of the Dystrophin-Glycoprotein Complex, and T-tubule AbnormalitiesJournal of Biological Chemistry, 2001
- In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammationNature Medicine, 2000
- THE CAVEOLAE MEMBRANE SYSTEMAnnual Review of Biochemistry, 1998
- Plasma membrane caveolae mediate the efflux of cellular free cholesterolBiochemistry, 1995
- Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate.The Journal of cell biology, 1992